Disclosures for "Astrocyte-derived HB-EGF promotes recovery from autoimmune CNS inflammation and is a potential target in progressive disease")
-
Mr. Linnerbauer has nothing to disclose.
-
Mrs. Loesslein has nothing to disclose.
-
Dr. Tsaktanis has nothing to disclose.
-
The institution of Prof. Jagodic has received research support from Swedish Research Council. The institution of Prof. Jagodic has received research support from EU Horizon 2020 (MultipleMS). The institution of Prof. Jagodic has received research support from European Research Council (ERC-CoG).
-
Dr. Quintana has nothing to disclose.
-
Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. Rothhammer has received research support from German Research Foundation. The institution of Prof. Rothhammer has received research support from European Research Council.